Liraglutide - NDC Database
13 records found
Page:
0480-7250 Aug 28, 2025
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Teva Pharmaceuticals, Inc.
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Teva Pharmaceuticals, Inc.
14403-3400 Dec 24, 2024
Liraglutide 18 mg/3ml Subcutaneous Injection, Solution by Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
Liraglutide 18 mg/3ml Subcutaneous Injection, Solution by Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
81607-018 Jan 21, 2026
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Orbicular Pharmaceutical Technologies Private Limited
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Orbicular Pharmaceutical Technologies Private Limited
81607-019 Feb 26, 2026
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Orbicular Pharmaceutical Technologies Private Limited
Liraglutide 6 mg/ml Subcutaneous Injection, Solution by Orbicular Pharmaceutical Technologies Private Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.